The evaluation of the fibromyalgia patients;La valutazione del paziente fibromialgico

Reumatismo

Volumn 60, Issue SUPPL. 1, 2007, Pages 36-49

  Atzeni, Fabiola ^a   Salaffi, F ^b   Bazzichi, L ^c   Gracely, R H ^d   Carignola, R ^e   Torta, R ^e   Gorla, R ^f   Marsico, A ^g   Ceccherelli, F ^h   Cazzola, M ⁱ   Buskila, D ^j   Spath, M ^k   Di Franco, M ^l   Biasi, G ^m   Cassisi, G ⁿ   Stisi, S ^o   Casale, R ^p   Altomonte, L ^q   Arioli, G ^r   Alciati, A ^a   Leardini, G ^s   Marinangeli, F ^t   Giamberardino, M A ^u   Sarzi Puttini, P ^a   more..

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY OF BRESCIA   (Italy)

^g Hospital of Taranto   (Italy)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ Unit of Rehabilitative Medicine 'Hospital of Circolo'   (Italy)

^j BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^k LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^l SAPIENZA UNIVERSITY OF ROME   (Italy)

^m UNIVERSITY OF SIENA   (Italy)

ⁿ Rheumatology Branch   (Italy)

^o G RUMMO HOSPITAL   (Italy)

^p IRCCS   (Italy)

^q S EUGENIO HOSPITAL   (Italy)

^r General Hospital of Pieve di Coriano   (Italy)

^s SS Giovanni e Paolo Hospital   (Italy)

^t UNIVERSITY OF L'AQUILA   (Italy)

^u UNIVERSITY OF CHIETI   (Italy)

more..

Author keywords

Biomarkers; Clinimetria; Clinimetric approaches; Functional magnetic resonance; Polisonnografia; Polysomnography; Risonanza magnetica funzionale; Tilting test; Tilting test. Parole chiave Biomarkers

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; FIBROMYALGIA; HUMAN; METABOLISM; PAIN ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; QUALITY OF LIFE; QUESTIONNAIRE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TILT TABLE TEST;

BIOLOGICAL MARKERS; FIBROMYALGIA; HUMANS; PAIN MEASUREMENT; POSITRON-EMISSION TOMOGRAPHY; QUALITY OF LIFE; QUESTIONNAIRES; TILT-TABLE TEST; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 69249222903     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: 10.4081/reumatismo.2008.1s.36     Document Type: Article

References (97)

1. Wolfe F, Smythe HA, Yunus MD. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160-72.
2. Magaldi M, Moltoni I, Biasi G, Marcolongo R. Modifications of calcium and magnesium ions in the intracellular fibromialgica pathophysiology of the syndro-me. Minerva Med 2000; 91: 137-40.
3. Wolfe F, K Ross, Russell AJ, Herbert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19-28.
4. Salaffi F, De Angelis R, Stancati A, Grassi W, Arche Pain M. Prevalence Investigation Group (MAPPING) study. Health-related quality of life in multiple musculoskeletal conditions: a cross-sectional population based epidemiological study. II. The MAPPING study. Clin Exp Rheumatol 2005; 23: 829-39.
5. Cook DB, Lange G, Ciccone DS, Liu WC, Steffener J, Natelson BH. Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol. 2004, 31: 364-78.
6. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum. 2002, 46: 1333-43.
7. Buskila D, Sarzi-Puttini P, Atzeni F, Stisi S, Carrabba M. La sindrome fibromialgica: recenti acquisizioni. Progres Reum 2005; 6 (suppl 1): 148-57.
8. Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003; 106: 337-45.
9. Mease PJ, Clauw DJ, LM. Arnold, Goldenberg DL, Witter J, Williams DA, et al. Fibromyalgia syndrome. OMERACT 7 Workshop. J Rheumatol 2005; 32: 2270-7.
10. Mease P. Fibromyalgia syndrome. review of clinical presentation, pathogenesis, outcome measures and treatment. J Rheumatol 2005; 32: 6-21.
11. Sarzi-Puttini P, Atzeni F. La sindrome fibromialgica. Riabilitazione reumatologica approccio multidisciplinare. Ed. S. Maddali Bongi. 2008; 979-94.
12. Wilson RB, Gluck OS, Tesser JR, Rice JC, Meyer A, Bridges AJ. Antipolymer antibody reactivity in a subset of patients with fibromyalgia correlates with severity. J Rheumatol 1999; 26: 402-7.
13. Fischer HP, Muller A, Fiehn W, Eich W. Antibodies against serotonin have no diagnostic relevance in patients with fibromyalgia syndrome. J Rhe-umatol 2001; 28: 595-600.
14. Bazzichi L, Rossi A, Giuliano T, De Feo F, Giacomelli C, Consensi A, et al. Association between thyroid autoimmunity and fibromyalgic disease severity. Clin Rheumatol 2007; 9.
15. Werle And Jakel HP, Muller A, Fischer HP, Fiehn W. Eich Serum Hyaluronic acid levels are elevated in arthritis patients, but normal and not associated with clinical data in patients with fibromyalgia syndrome. Lab Clin 2005; 51: 11-19.
16. Wigley RD, B, EM Chambers. Hyaluronic acid serum levels in fibromyalgia, non-specific arm disorder, and controls. J Rheumatol 2001; 28: 2563.
17. Maes M, Verkerk R, Delmeire L, Van Gastel A, Van Hunsel F, Scharpe S. Serotonergic markers and lowered plasme branched-chain amino-acid concentrations in fibromyalgia. Psychiatry Res 2000; 97: 11-20.
18. Sprott H, A Muller, H. Heine. Collagen cross-links in fibromyalgia syndrome. Z. Rheumatol 1998; 57: 52-5.
19. Jaschko G, Hepp U, Berkhoff M, Schmet M, Michel BA, Gay S, Sprott H. Serum serotonin levels are not useful in diagnosing fibromyalgia. Ann Rheum Dis 2007; 66: 1267-8.
20. Offenbaecher M, Bondy B, De Jonge S, Glatzeder K, Krüger M, Schoeps P, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 1999; 42: 2482-8.
21. Dorshkind K, Horseman ND. The roles of prolactin, growth hormone, insulin-like growth factor-1, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr Rev 2000; 21: 292-312.
22. Hocherel K, Farber L, S Ladenburger, Vosshage D, Stratz T, Muller W, Grobecker H. Effect of tropisetron on circulating catecholamines and other putative biochemical markers in serum of patients with fibromyalgia. Scand J Rheumatol 2000; 113: 46-8.
23. Bazzichi L, Rossi A, Massimetti G, Giannaccini G, Giuliano T, De Feo F, et al. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 2007; 25: 225-30.
24. Bagis S, Tamer L, Sahin G, Bilgin R, H Guler, Ercan B, Erdogan C. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int 2005; 25: 188-90.
25. Lund I Lundeberg T, Carleson J, H Sonnerfors, Uhrlin B Svensson E. Corticotropin releasing factor in the urine: a possible biochemical markers of fibromyalgia. Responses to massage and guided relaxation. Neurosci Lett 2006; 403: 166-71.
26. Baraniuk JN, Casado B, H Maibach, Clauw DJ, Pannell LK, Hess SS. A chronic fatigue syndrome-related proteome in human cerebrospinal fluid. BMC Neurol 2005; 5: 22.
27. McLean S, Williams DA, Stein PK, Harris RE, Lyden AK, Whalen G, et al. Cerebrospinal fluid corticotropinreleasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromialgia. Neuropsychopharmacology 2006; 31: 2776-82.
28. Sarchielli P, Alberti A, Candeliere A, Floridi A, Capocchi G, Calabresi P. Glial cell line-derived neurotrophic factor and somatostatin levels in cerebrospinal fluid of patients affected by migraine and fibromialgia. Cephalalgia 2005; 26: 409-15.
29. Bazzichi L, Giannaccini G, Betti L, Mascia G, Fabbrini L, Italiani P, et al. Alteration of serotonin transporter density and activity in Fibromyalgia. Arthritis Res Ther 2006; 8: R99 (doi: 10.1186/ar1982).
30. Bazzichi L, Giannaccini G, Betti L, Italiani P, Fabbrini L, De Feo F, et al. Peripheral benzodiazepine receptors on platelets of fibromyalgia patients. Clin Biochem 2006, 39: 867-72.
31. Kaufmann I, Eisner C, Richter P, Huge V, Beyer A, Chouker A, et al. Lymphocyte subsets and the role of Th1/Th2 balance in stressed chronic pain patients. Neuroimmunomodulation 2008; 14: 272-80.
32. Kim SH, Kim DH, Oh DH, Clauw DJ. Characteristic electron microscopic findings in the skin of patients with fibromialgia-preliminary study. Clin Rheumatol. 2008; 27: 219-23.
33. Nampiaparampil DE, Shmerling RH. A review of fibromyalgia. Am J Manag Care 2004; 10: 794-800.
34. Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: what we know and what we need know. Best Pract Res Clin Rheumatol 2003;17:685-701.
35. Daoud KF, Barkhuizen A. Rheumatic mimics and selected triggers of fibromyalgia. Curr Pain Headache Rep 2002; 6: 284-288.
36. Wolfe F, Cathey MA, Kleinheksel SM. Fibrositis (fibromyalgia) in rheumatoid arthritis. J Rheumatol 1984; 11: 814-8.
37. Middleton GD, McFarlin JE, Lipsky PE. The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1181-8.
38. Bonafede RP, Downey DC, Bennetr RM. An association of fibromyalgia with primary Sjogren's syndrome: a prospective study of 72 patients. J Rheumatol 1995; 22: 133-6.
39. Wolfe F, Cathey MA. Prevalence of primary and secondary fibrositis. J Rhematol 1983; 33: 160-72.
40. Esther H, Barkhuizen A. Update on Rheumatologic mimics of fibromyalgia. Curr Pain Head Rep 2006; 10: 327-332.
41. Klippel JH, Crofford LJ, Stone JH, Weyand CM, eds. Primer on the rheumatic diseases. Atlanta: Arthritis Foundation; 2001.
42. Ostergaard M., Ejbjerg B, Szkudlarek M. Imaging in early rheumatoid arthritis: roles of magnetic resonance imaging, ultrasonography, conventional radiography and computed tomography. Best Pract Res Clin Rheum-atol 2005; 19: 91-116.
43. Joshua F, Lassere M, Bruyn GA, Szkudlarek M, Naredo E, Schmidt WA, et al. Summary findings of a systematic review of the ultrasound assessment of synovitis. J Rheumatol 2007; 34: 839-47.
44. Grassi W, Filippucci E. Ultrasonography and the rheumatologist. Curr Opin Rheumatol 2007; 19: 55-60.
45. Khan MA. Update on spondyloarthropathies. Ann Intern Med 2002; 136: 896-907.
46. Fitzcharles MA, Esdaile J. The overdiagnosis of fibromyalgia syndrome. Am J Med 1997; 103: 44-50.
47. Zochling J, Baraliakos X, Hermann KG, Braun J. Magnetic resonance imaging in ankylosing spondylitis. Curr Opin Rheumatol 2007; 19: 346-52.
48. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period. Medicine 2003; 82: 299-308.
49. Fitzpatrick TB, Johnson RA, Wolff K, eds et al. Color Atlas and Synopsis of Clinical Dermatology. New York: The McGraw-Hill Companies; 1997.
50. Martinez-Lavin M. Overlap of Fibromyalgia with other medical conditions. Curr Pain Head Rep 2001; 5: 347-50.
51. Martinez-Lavin M, Hermosillo AG. Autonomic nervous system dysfunction may explain the multi-system features of fibromyalgia. Semin Arthritis Rheum 2000; 29: 197-9.
52. Salaffi F, Carotti M, Argalia G, Salera D, Giuseppetti GM, Grassi W. Usefulness of ultrasonography and color Doppler sonography in the diagnosis of major salivary gland diseases. Reumatismo 2006; 58: 138-56.
53. Al-Allaf AW, Mole PA, Paterson CR, Pullar T. Bone health in patients with fibromyalgia. Rheumatology 2003; 42: 1202-6.
54. Briani C, Doria A, Sarzi-Puttini P, Dalakas MC. Update on idiopatic inflammatory myopathies. Autoimmunity 2006; 39: 161-70.
55. Pamuk ON, Cakir N. The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms. Clin Rheumatol 2007; 26: 55-9.
56. Garrison RL, Breeding PC. A metabolic basis for fibromyalgia and its related disorders: the possible role of resistance to thyroid hormone. Med Hypotheses 2003; 61: 182-9.
57. Buskila D. Hepatitis C-associated arthritis. Curr Opin Rheumatol 2000; 12: 295-9.
58. Adak B, Tekeoglu I, Ediz L, Budancamanak M, Yazgan T, Karahocagil K, et al. Fibromyalgia frequency in hepatitis B carriers. J Clin Rheumatol 2005; 11: 157-9.
59. Reilly PA. The differential diagnosis of generalized pain. Baillieres Best Pract Res Clin Rheumatol 1999; 13: 391-401.
60. Dreyer L, Mellemkjaer L, Kendall S, Jensen B, Danneskiold-Samsøe B, Bliddal H. Increased cancer risk in patients referred to hospital with suspected fibromyalgia. J Rheumatol 2007; 34: 201-6.
61. Martinez-Lavin M. Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia. Arthritis Res Ther 2007; 9: 216 (doi: 10.1186/ar 2146).
62. Furlan R, Colombo S, Perego F, Atzeni F, Diana A, Barbic F, et al. Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia. J Rheumatol. 2005; 32: 1787-93.
63. Sarzi-Puttini P, Rizzi M, Andreoli A, Panni B, Pecis M, Colombo S, et al. Hypersomnolence in fibromyalgia syndrome. Clin Exp Rheumatol 2002; 20: 69-72.
64. Rizzi M, Sarzi-Puttini P, Atzeni F, Capsoni F, Andreoli A, Pecis M, et al. Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia? J Rheumatol 2004; 31: 1193-9.
65. Mountz JM, Bradley LA, Modell JG, Alexander RW, Triana-Alexander M, Aaron LA, et al. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995; 38: 926-38.
66. Kwiatek R, Barnden L, Tedman R, Jarrett R, Chew J, Rowe C, Pile K. Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum. 2000; 43: 2823-33.
67. Cohen-Gadol AA, Bradley CC, Williamson A, Kim JH, Westerveld M, Duckrow RB, et al. Normal magnetic resonance imaging and medial temporal lobe epilepsy: the clinical syndrome of paradoxical temporal lobe epilepsy. J Neurosurg 2005; 103: 768-9.
68. Iadarola MJ, Max MB, Berman KF, Byas-Smith MG, Coghill RC, Gracely RH, Bennett G. Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain. Pain 1995; 63: 55-64.
69. Di Piero V, Jones AK, Iannotti F, Powell M, Perani D, Lenzi GL, Frackowiak RS. Chronic pain: A PET study of the central effects of percutaneous high cervical cordotomy. Pain 1991; 46: 9-12.
70. Petzke F, Clauw DJ, Ambrose K, Khine A, Gracely RH. Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation. Pain 2003; 105: 403-13.
71. Grant MA, Farrell MJ, Kumar R, Clauw DJ, Gracely RH. fMRI evaluation of pain intensity coding in fibromyalgia patients and controls. Arthritis Rheum 2001; 44.
72. Giesecke T, Gracely R H, Williams DA, Geisser M, Petzke F, Clauw DJ. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 2005; 52: 1577-84.
73. Burton AK, Tillotson KM, Main CJ, Hollis S. Psy chosocial predictors of outcome in acute and subchronic low back trouble. Spine 1995; 20: 722-8.
74. Gracely RH, Geisser ME, Giesecke T, Grant MA, Petzke F, Williams DA, Clauw DJ. Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 2004; 127: 835-43.
75. Kuchinad A Scweinhardt P Seminowicz DA Wood PB Chizh BA Bushnell MC. Accelerated brain gray matter loss in fibromyalgia patients: premature. J Neurosci 2007; 27: 4004-7.
76. Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 2007; 2: 10000-6.
77. Mäntyselkä P, Kumpusalo E, Ahonen R, Kumpusalo A, Kauhanen J, Viinamäki H, et al. Pain as a reason to visit the doctor; a study in Finnish primary health care. Pain 2001; 89: 175-80.
78. Macfarlane GJ, Morris S, Hunt IM, Benjamin S, Mc-Beth J, Papageorgiou AC, et al. Chronic widespresd pain in the community: the influence of psychological symptoms and mental disorder on healthcare seeking behavior. J Rheumatol 1999; 26: 413-9.
79. Salaffi F, Carotti M. Semeiotica e valutazione del dolore muscoloscheletrico. In "Clinimetria delle malattie muscoloscheletriche. Scale e punteggi" Ed Mattioli 1885; 19-58, 2007.
80. Scott-Huskisson EC. Graphic Representation of pain. Pain 1976; 2: 175-84.
81. Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain 2004; 8: 283-91.
82. Melzack R. The McGill Pain questionnaire: major properties and scoring methods. Pain 1985; 1: 85-92.
83. Salaffi F, Nolli M, Cavalieri F, Ferraccioli GF. Confronto tra indici algometrici nella valutazione dell'esperienza algica in Reumatologia. Utilità della versione italiana del questionario algologico McGill. Reumatismo 1990; 42: 19-31.
84. Sinclair D, Starz T, Turk D. The manual Tender Point Survey. [Internet]. [Accessed July, 2005]. Available from National Fibromyalgia Association: http://fmawa re.org/doctor/tenderpt.htm
85. Fordyce WE, Lansky D, Calsyn DA, Shelton JL, Stolov WC, Rock DL. Pain measurement and pain behavior. Pain 1984; 18: 53-69.
86. Scudds RA, Rollman GB, Harth M, McCain A. Pain perception and personality measures as discriminations in the classification of fibrositis. J Rheumatol 1987; 14: 563-9.
87. Belza BL, Henke CJ, Yelin EH, Epstein WV, Gillis CL. Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res 1993; 42: 93-9.
88. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 2003; 1: 79.
89. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The Fatigue Severity Scale. Application to patients with multiple sclerosi and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121-3.
90. Hays R, Stewart A. Measuring functioning and well-being. In: Stewart A, Ware J, editors. Durham, NC: Duke University Press; 1992: 232-59.
91. Franchignoni F, Salaffi F. Generic and specific measures for outcome assessment in orthopaedic and rheumatologic rehabilitation. In: Assessment in Physical Medicine and Rehabilitation-Advances in Rehabilitation. M. Barat, F. Franchignoni Eds. 2004; 16: 45-77.
92. Ware JE Jr, Sherbourne CD. The MOS 36-item short form health survey (SF-36). Conceptual frame-work and item selection. Med Care 1992; 30: 473-81.
93. Hunt SM, McEven J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J Roy Coll Gen Pract 1985; 35: 185-8.
94. Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991; 18: 728-33.
95. Sarzi-Puttini P, Atzeni F, Fiorini T, Panni B, Randisi G, Turiel M, et al. Validation of an Italian version of the Fibromyalgia Impact Questionnaire (FIQ-Q). Clin Exp Rheumatol 2003; 21: 459-64.
96. Simms RW, Felson DT, Goldenberg DL. Development of preliminary criteria for response to treatment in fibromyalgia syndrome. J Rheumatol 1991; 18: 1558-63.
97. Dunkl PR, Taylor AG, McConnell GG, Alfano AP, Conaway MR. Responsiveness of fibromyalgia clinical trial outcome measures. J Rheumatol 2000; 27: 2683-91.